Liquid–Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities
Cellular Reprogramming · 2026
DOI: 10.1177/21524971261453859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Reprogramming, 2026. Verfasst von Yaou Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, …. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Cell Communication, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Taishan Scholars Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor-associated fluids, including interstitial, vascular, and lymphatic fluids, are increasingly recognized as active regulators of cancer progression rather than passive transport media within the tumor microenvironment. As an integrative working concept, liquid–cell interactions describe how these fluids regulate biochemical signaling, extracellular vesicle trafficking, metabolite exchange, and force transmission among cancer, stromal, and immune cells. Hydrodynamic forces, chemical gradients, extracellular vesicles (EVs), and damage-associated signals jointly shape proliferation, invasion, metabolic reprogramming, angiogenesis, immune escape, and inflammatory propagation. Perturbations in flow, viscosity, pH, and fluid composition further remodel tissue architecture and reprogram cell states, thereby influencing therapeutic response. Clinically, liquid-phase biomarkers, including circulating cytokines, nucleic acids, EVs, and circulating tumor cells, support early detection, real-time monitoring, and resistance prediction. Therapeutically, strategies that normalize fluid dynamics, modulate soluble signaling networks, or block vesicle trafficking show translational promise and may enhance standard treatments. This review synthesizes recent advances from mechanisms to clinical applications and highlights the liquid phase as a distinct regulatory dimension of the tumor microenvironment with diagnostic and therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Shandong Provincial Key Medical and Health Laboratory for Endocrinology and Metabolic Diseases, Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
ORCID-Profile: Fang Han
Förderung
- Taishan Scholars Project of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Zhang, K., Ma, Y., Tian, Z., Kan, C., Han, F., & Sun, X. (2026). Liquid–Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities. Cellular Reprogramming. https://doi.org/10.1177/21524971261453859
Vancouver
Wang Y, Zhang K, Ma Y, Tian Z, Kan C, Han F, et al. Liquid–Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities. Cellular Reprogramming. 2026. doi:10.1177/21524971261453859
BibTeX
@article{Wang2026,
author = {Wang, Yaou and Zhang, Kexin and Ma, Yujie and Tian, Zhenghui and Kan, Chengxia and Han, Fang and Sun, Xiaodong},
title = {Liquid–Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities},
journal = {Cellular Reprogramming},
year = {2026},
doi = {10.1177/21524971261453859}
}
EUVIMED